Company Secretary and Compliance Officer appointed with effect from 5th August, 2026
Dipna Pharmachem's Board approved the appointment of Mr. Shyam Sundar Lohia as Company Secretary and Compliance Officer with effect from 5th August, 2026.
By ScoutQuest · · 2 min read
- Appointee
- Mr. Shyam Sundar Lohia
- Role
- Company Secretary and Compliance Officer
- Effective Date
- 5th August, 2026
Board decision at a glance
- The Board of Directors of Dipna Pharmachem considered and approved the appointment of Mr. Shyam Sundar Lohia as the Company Secretary and Compliance Officer of the company.
- The appointment takes effect from 5th August, 2026, the same day the Board meeting was held.
- The reason recorded for the change is simply Appointment.
Who has been appointed
- Mr. Shyam Sundar Lohia is a qualified Company Secretary with over 12 years of experience.
- His stated experience covers corporate secretarial functions, regulatory compliance, corporate governance, FEMA compliances, SEBI regulations and ROC updates.
- The profile also lists work on compliance for listed and unlisted companies, board and shareholder meetings, legal documentation, due diligence, mergers and amalgamations, and liaison with regulatory authorities.
- The update states he is not related to any of the directors of the company.
Why this role matters
The Company Secretary and Compliance Officer is the person through whom a listed company deals with the stock exchanges and the market regulator on routine compliance — board and shareholder meeting records, disclosures, and statutory updates. Having a named officer in place is part of keeping that compliance pipeline running.
What the announcement tells an investor
- The company has formally filled, and publicly named, an officer responsible for secretarial and compliance work.
- The appointee's stated background is in compliance and governance rather than in operations or business development.
- The update is a disclosure of a board decision; it contains no financial figures, no change in share capital, and no commercial or order-related information.
How to read it
This is a routine board-level appointment disclosure. Its relevance to investors is about who handles the company's compliance and regulatory interface going forward, not about earnings or business performance.
Also from Dipna Pharmachem
Two independent directors resign; Nirav Soni joins board and chairs three committees
24 Oct 2026
Board appoints additional non-executive director; two independent directors resign, three committees reconstituted
24 Oct 2026
Company Secretary and Compliance Officer appointed w.e.f. 5th August, 2026
23 Oct 2026
More numbers
- Experience of the appointed Company Secretaryover 12 years
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.